Edward Albini

Ed Albini is a seasoned financial executive with extensive experience in the biopharmaceutical industry, currently serving as CFO at Sutro Biopharma, Inc. since January 2013. Previously, Ed held senior financial leadership roles as Senior Vice President and CFO at Itero Biopharmaceuticals, Inc. from 2009 to 2016, and as Vice President and CFO at both Novacea (2004-2009) and Lynx Therapeutics (1997-2004). Ed's career began at Genentech, where tenure lasted from 1983 to 1997 as Director of Financial Planning & Analysis. Ed holds an MBA in Finance from the University of California, Berkeley's Haas School of Business and a Bachelor's degree in Accounting from Santa Clara University.